IDEX Corporation logo

IDEX Corporation

IEX

NYSEIndustrialsIndustrial - Machinery

Latest quote

$234.41

+$0.64 · +0.27%

Aug 21, 3:59 PM ET

IEX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

68

Undervalued

Momentum

48

Neutral

Sentiment

72

Bullish

Risk resilience

81

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

IDEX Corporation is an international enterprise specializing in engineered solutions across diverse sectors. The company operates through three primary business units: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT division is responsible for the design, production, and distribution of a range of fluid-handling equipment, including positive displacement pumps, flow meters, and injectors, alongside offering flow monitoring and related services. Its applications span the food, chemical, general industrial, water management, agricultural, and energy industries. Under the HST umbrella, IDEX develops and supplies precision components and systems for health and scientific applications. This includes advanced fluidic devices, various types of pumps (rotary lobe, centrifugal, positive displacement), roll compaction and drying technologies, pneumatic components, and sealing solutions, as well as biocompatible medical devices, optical components, and precision photonic solutions. Key markets for this segment encompass food and beverage, pharmaceutical, cosmetics, marine, chemical, wastewater treatment, life sciences, research, and defense. Finally, the FSDP segment delivers critical equipment for emergency services, such as firefighting pumps, valves, rescue tools, and lifting bags. It also provides engineered stainless steel banding and clamping devices for industrial and commercial use, alongside specialized precision equipment for dispensing, metering, and mixing colorants and paints for retail and commercial clients. IDEX Corporation was founded in 1987 and maintains its headquarters in Northbrook, Illinois.

Industry
Industrial - Machinery
Sector
Industrials
Headquarters
US
CEO
Eric D. Ashleman
Listed since
Jun 2, 1989
Employees
8,700

Market position

Volume
478.91K
0.68× average
Average volume
699.8K
Average daily volume
Market cap
17.28B USD
Beta
0.98
Market reference 1

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
14.67B USD
P/E (TTM)
33.63×
P/B (TTM)
4.33×
P/S (TTM)
4.82×
EV / EBITDA
16.23×
Earnings yield
3.61%
Free cash flow yield
4.60%
Dividend yield
1.23%

Profitability & efficiency

Gross margin
44.70%
Operating margin
20.75%
Net margin
14.49%
Return on equity
12.00%
Return on assets
6.98%
Return on invested capital
8.61%

Financial health

Debt / equity
0.47×
Current ratio
2.86×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends54%39%25%10%Gross margin, FY2021: 49.24%Gross margin, FY2022: 50.11%Gross margin, FY2023: 49.57%Gross margin, FY2024: 46.40%Gross margin, FY2025: 44.51%Operating margin, FY2021: 23.65%Operating margin, FY2022: 24.81%Operating margin, FY2023: 22.93%Operating margin, FY2024: 21.32%Operating margin, FY2025: 20.82%Net margin, FY2021: 16.25%Net margin, FY2022: 18.44%Net margin, FY2023: 18.21%Net margin, FY2024: 15.45%Net margin, FY2025: 13.98%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.24%. Gross margin FY2022 50.11%. Gross margin FY2023 49.57%. Gross margin FY2024 46.40%. Gross margin FY2025 44.51%. Operating margin FY2021 23.65%. Operating margin FY2022 24.81%. Operating margin FY2023 22.93%. Operating margin FY2024 21.32%. Operating margin FY2025 20.82%. Net margin FY2021 16.25%. Net margin FY2022 18.44%. Net margin FY2023 18.21%. Net margin FY2024 15.45%. Net margin FY2025 13.98%.

Income trends

Revenue

3.46B USD+5.77%

Operating income

720M USD+3.31%

Net income

483.2M USD-4.32%
Income trends across reported periods3.76B USD2.56B USD1.35B USD148.59M USDRevenue, FY2021: 2.76B USDRevenue, FY2022: 3.18B USDRevenue, FY2023: 3.27B USDRevenue, FY2024: 3.27B USDRevenue, FY2025: 3.46B USDOperating income, FY2021: 654M USDOperating income, FY2022: 789.5M USDOperating income, FY2023: 750.7M USDOperating income, FY2024: 696.9M USDOperating income, FY2025: 720M USDNet income, FY2021: 449.4M USDNet income, FY2022: 586.9M USDNet income, FY2023: 596.1M USDNet income, FY2024: 505M USDNet income, FY2025: 483.2M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.76B USD. Revenue FY2022 3.18B USD. Revenue FY2023 3.27B USD. Revenue FY2024 3.27B USD. Revenue FY2025 3.46B USD. Operating income FY2021 654M USD. Operating income FY2022 789.5M USD. Operating income FY2023 750.7M USD. Operating income FY2024 696.9M USD. Operating income FY2025 720M USD. Net income FY2021 449.4M USD. Net income FY2022 586.9M USD. Net income FY2023 596.1M USD. Net income FY2024 505M USD. Net income FY2025 483.2M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue3.46B USD3.27B USD3.27B USD3.18B USD2.76B USD
Cost of goods sold1.92B USD1.75B USD1.65B USD1.59B USD1.4B USD
Gross profit1.54B USD1.52B USD1.62B USD1.59B USD1.36B USD
Research and development178.6M USD175.9M USD156.8M USD133M USD
Selling, general, and administrative818.8M USD749M USD696.2M USD648.1M USD573.2M USD
Operating expenses818.8M USD819.8M USD872.1M USD804.9M USD707.5M USD
Interest expense64.4M USD44.5M USD51.7M USD40.7M USD37.7M USD
Depreciation and amortization206.5M USD175.6M USD152.1M USD119.7M USD103M USD
Operating income720M USD696.9M USD750.7M USD789.5M USD654M USD
Net income483.2M USD505M USD596.1M USD586.9M USD449.4M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
100%
11 beats, 0 misses, 0 met estimates
Average EPS surprise
+4.81%
11 comparable reports
Latest EPS result
2.32
Estimate 2.11 · Beat by 9.95%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates2.412.121.841.55Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 4, 2025: actual 2.04, estimate 2.03, surprise +0.49%, Beat. Q2 2025, reported May 1, 2025: actual 1.75, estimate 1.64, surprise +6.71%, Beat. Q3 2025, reported Jul 30, 2025: actual 2.07, estimate 2, surprise +3.50%, Beat. Q4 2025, reported Oct 29, 2025: actual 2.03, estimate 1.93, surprise +5.18%, Beat. Q1 2026, reported Feb 4, 2026: actual 2.1, estimate 2.04, surprise +2.94%, Beat. Q2 2026, reported Apr 29, 2026: actual 2, estimate 1.77, surprise +12.99%, Beat. Q3 2026, reported Jul 29, 2026: actual 2.32, estimate 2.11, surprise +9.95%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 2.22, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates967.12M901.13M835.13M769.14MQ1 '25MissQ2 '25BeatQ3 '25MissQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 4, 2025: actual 862.9M USD, estimate 866.07M USD, surprise -0.37%, Miss. Q2 2025, reported May 1, 2025: actual 814.3M USD, estimate 806.33M USD, surprise +0.99%, Beat. Q3 2025, reported Jul 30, 2025: actual 865.4M USD, estimate 871.98M USD, surprise -0.75%, Miss. Q4 2025, reported Oct 29, 2025: actual 878.7M USD, estimate 861.44M USD, surprise +2.00%, Beat. Q1 2026, reported Feb 4, 2026: actual 899.1M USD, estimate 882.27M USD, surprise +1.91%, Beat. Q2 2026, reported Apr 29, 2026: actual 886.9M USD, estimate 845.58M USD, surprise +4.89%, Beat. Q3 2026, reported Jul 29, 2026: actual 920.6M USD, estimate 905.37M USD, surprise +1.68%, Beat. Q4 2026, reported Oct 28, 2026: actual —, estimate 929.92M USD, surprise —, Comparison unavailable.

IEX peers

ETFs holding IEX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research IEX

research.disclaimer